Authority Content Program Drives $150M in Partner & VC Inquiries
The Challenge
GenLink BioTherapeutics was looking to secure strategic partnerships and VC interest for their therapeutics pipeline. Their scientific breakthroughs were complex, and their existing website did not present their insights in an accessible, authority-establishing way for investors.
The Petro Approach
Petro designed an executive thought leadership and content distribution strategy. We interviewed GenLink's chief scientists, turning highly technical science into compelling B2B articles and industry white papers.
The Technical Solution
We launched an editorial hub on their site, publishing B2B thought leadership articles, scientific explainers, and gated industry reports, supported by an executive social distribution program.
The Business Results
The thought leadership hub established GenLink as a major voice. Organic search click-through rates (CTR) rose by 304%, and the program brought in qualified VC and pharmaceutical partner inquiries representing a combined $150M in potential value.
Delivery transparency
During this engagement, GenLink BioTherapeutics tracked campaign analytics, spend optimization, and project deliverables in real time through our shared reporting pipelines.
“Petro knows how to translate deep science into B2B impact. Their content has given us a direct line to institutional investors.”
CEO & Founder, GenLink BioTherapeutics
Applied Services
Ready for similar results?
Let us deploy our senior thinkers and real-time dashboard on your marketing campaigns.